BioWorld Asia

May 7, 2003

European Sector Experiences Falloff In Revenues, Employees

LONDON - The European biotechnology sector in 2002 saw revenues and employee numbers fall for the first time in a decade, according to Ernst & Young's 10th annual survey of the sector. (BioWorld International) Read More

Phytopharm Enters Potentially Lucrative Deal With Yamanouchi

Estrogen Receptor Modulators May Have Anticancer Role, Study Shows

Vernalis Raising £14.1 Million As It Negotiates Sale Of Company

Israeli Biotech Continues Growth With Private, Government Support

Irish University-Industry Program Draws Funding, Foreign Partners

Serono Disagrees With Rejection Of Serostim For AIDS Wasting

Protherics Paying £17.9M In Notes, Shares For Acquisition Of Enact

Zealand, Wyeth Collaborate On Gap Junction Modulators

Hybrigenics Acquires Dutch Firm Semaia In 'Friendly' Stock Deal

Sloning Raises EUR4.3M In Second Round For DNA Cloning Program

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for June 11, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 9, 2026

3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

Skape Bio unlocks GPCR targets with de novo-designed miniproteins

BioWorld

Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...

New 5-HT2C receptor agonists reported in Hansoh patent

BioWorld Science

Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...

Pre-disease plasma signature may help redefine lung cancer risk

BioWorld

Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...